{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T16:14:08Z","timestamp":1773850448813,"version":"3.50.1"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T00:00:00Z","timestamp":1607904000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The incidence of chronic obstructive pulmonary disease (COPD) complicated with invasive pulmonary aspergillosis (IPA) has increased in the last two decades. The mechanism underpinning susceptibility to and high mortality of COPD complicated with IPA is unclear, and the role of T helper cells 17 (Th17 cells) in the compound disease remains unknown. Therefore, this study aimed to assess the function of Th17 cells in COPD combined with IPA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>COPD, IPA, and COPD+IPA mouse models were established in male wild type C57\/BL6 mice. The amounts of Th17 cells and retinoic acid-related orphan receptors \u03b3t (ROR\u03b3t) were tested by flow cytometry. Then, serum interleukin (IL)-17 and IL-23 levels were detected by enzyme-linked immunosorbent assay (ELISA) in the control, COPD, IPA and COPD+IPA groups. In addition, COPD+IPA was induced in IL-17 knockout (KO) mice, for determining the role of Th17 cells in COPD+IPA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Compared with the COPD group, the COPD+IPA group showed higher amounts of blood ROR\u03b3t ([35.09\u200a\u00b1\u200a16.12]% <jats:italic toggle=\"yes\">vs<\/jats:italic>. [17.92\u200a\u00b1\u200a4.91]%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.02) and serum IL-17 (17.96\u200a\u00b1\u200a9.59\u200apg\/mL <jats:italic toggle=\"yes\">vs<\/jats:italic>. 8.05\u200a\u00b1\u200a4.44\u200apg\/mL, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.02), but blood ([5.18\u200a\u00b1\u200a1.09]% <jats:italic toggle=\"yes\">vs.<\/jats:italic> [4.15\u200a\u00b1\u200a0.87]%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.28) and lung levels of Th17 cells ([1.98\u200a\u00b1\u200a0.83]% <jats:italic toggle=\"yes\">vs<\/jats:italic>. [2.03\u200a\u00b1\u200a0.98]%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.91), lung levels of ROR\u03b3t ([9.58\u200a\u00b1\u200a6.93]% <jats:italic toggle=\"yes\">vs<\/jats:italic>. [9.63\u200a\u00b1\u200a5.98]%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.49) and serum IL-23 (51.55\u200a\u00b1\u200a27.82\u200apg\/mL <jats:italic toggle=\"yes\">vs<\/jats:italic>. 68.70\u200a\u00b1\u200a15.20\u200apg\/mL, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.15) showed no significant differences. Compared with the IPA group, the COPD+IPA group displayed lower amounts of blood ([5.18\u200a\u00b1\u200a1.09]% <jats:italic toggle=\"yes\">vs<\/jats:italic>. [9.21\u200a\u00b1\u200a3.56]%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.01) and lung Th17 cells ([1.98\u200a\u00b1\u200a0.83]% <jats:italic toggle=\"yes\">vs<\/jats:italic>. [6.29\u200a\u00b1\u200a1.11]%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.01) and serum IL-23 (51.55\u200a\u00b1\u200a27.82 pg\/mL <jats:italic toggle=\"yes\">vs<\/jats:italic>. 154.90\u200a\u00b1\u200a64.60\u200apg\/mL, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.01) and IL-17 (17.96\u200a\u00b1\u200a9.59 pg\/mL <jats:italic toggle=\"yes\">vs<\/jats:italic>. 39.81\u200a\u00b1\u200a22.37 pg\/mL, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.02), while comparable blood ([35.09\u200a\u00b1\u200a16.12]% <jats:italic toggle=\"yes\">vs<\/jats:italic>. [29.86\u200a\u00b1\u200a15.42]%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.25) and lung levels of ROR\u03b3t ([9.58\u200a\u00b1\u200a6.93]% <jats:italic toggle=\"yes\">vs<\/jats:italic>. [15.10\u200a\u00b1\u200a2.95]%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.18) were found in these two groups. Finally, <jats:italic toggle=\"yes\">Aspergillus<\/jats:italic> load in IL-17 KO COPD+IPA mice was almost 2 times that of COPD+IPA mice (1,851,687.69\u200a\u00b1\u200a944,480.43 <jats:italic toggle=\"yes\">vs<\/jats:italic>. 892,958.10\u200a\u00b1\u200a686,808.80, <jats:italic toggle=\"yes\">t<\/jats:italic>\u200a=\u200a2.32, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.02).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>These findings indicate that Th17 cells might be involved in the pathogenesis of COPD combined with IPA, with IL-17 likely playing an antifungal role.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cm9.0000000000001183","type":"journal-article","created":{"date-parts":[[2020,12,15]],"date-time":"2020-12-15T18:37:45Z","timestamp":1608057465000},"page":"555-563","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Th17 cells are involved in mouse chronic obstructive pulmonary disease complicated with invasive pulmonary aspergillosis"],"prefix":"10.1097","volume":"134","author":[{"given":"Wan-Ru","family":"Geng","sequence":"first","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China"},{"name":"Department of Respiratory Medicine, Affiliated Hospital of Inner Mongolia University for the Nationalities, Tongliao, Inner Mongolia 028000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang-Yong","family":"He","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The Second Hospital of Jilin University, Changchun, Jilin 130041, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao-Hui","family":"Tong","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,3,5]]},"reference":[{"key":"R1-20250603","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.rmed.2018.06.029","article-title":"The spectrum of pulmonary aspergillosis","volume":"141","author":"Kanj","year":"2018","journal-title":"Respir Med"},{"key":"R2-20250603","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1183\/09031936.00062206","article-title":"Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease","volume":"30","author":"Bulpa","year":"2007","journal-title":"Eur Respir J"},{"key":"R3-20250603","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s001340000768","article-title":"Chronic obstructive pulmonary disease patients with invasive pulmonary aspergillosis: benefits of intensive care","volume":"27","author":"Bulpa","year":"2001","journal-title":"Intensive Care Med"},{"key":"R4-20250603","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/j.1469-0691.2009.03015.x","article-title":"Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome","volume":"16","author":"Guinea","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"R5-20250603","doi-asserted-by":"crossref","first-page":"R5","DOI":"10.1186\/cc9402","article-title":"Clinical features of invasive bronchial-pulmonary aspergillosis in critically ill patients with chronic obstructive respiratory diseases: a prospective study","volume":"15","author":"He","year":"2011","journal-title":"Crit Care"},{"key":"R6-20250603","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","article-title":"A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients","volume":"186","author":"Blot","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"R7-20250603","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13054-014-0722-7","article-title":"Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes","volume":"19","author":"Taccone","year":"2015","journal-title":"Crit Care"},{"key":"R8-20250603","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/cid\/ciu337","article-title":"Immune correlates of protection in human invasive aspergillosis","volume":"59","author":"Camargo","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"(Suppl 1)","key":"R9-20250603","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1080\/13693780802140766","article-title":"Th17 cells in the setting of Aspergillus infection and pathology","volume":"47","author":"Zelante","year":"2009","journal-title":"Med Mycol"},{"key":"R10-20250603","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1002\/eji.200737409","article-title":"IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance","volume":"37","author":"Zelante","year":"2007","journal-title":"Eur J Immunol"},{"key":"R11-20250603","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.4049\/jimmunol.180.6.4022","article-title":"Lack of Toll IL-1R8 exacerbates Th17 cell responses in fungal infection","volume":"180","author":"Bozza","year":"2008","journal-title":"J Immunol"},{"issue":"(Suppl 2)","key":"R12-20250603","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1513\/AnnalsATS.201503-126AW","article-title":"Immune dysfunction in patients with chronic obstructive pulmonary disease","volume":"12","author":"Bhat","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"R13-20250603","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.4049\/jimmunol.0802622","article-title":"Peripheral T cell functions correlate with the severity of chronic obstructive pulmonary disease","volume":"182","author":"Zhu","year":"2009","journal-title":"J Immunol"},{"key":"R14-20250603","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"key":"R15-20250603","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12931-015-0251-1","article-title":"Acute exacerbations of chronic obstructive pulmonary disease are associated with decreased CD4+ & CD8+ T cells and increased growth & differentiation factor-15 (GDF-15) in peripheral blood","volume":"16","author":"Freeman","year":"2015","journal-title":"Respir Res"},{"key":"R16-20250603","doi-asserted-by":"crossref","first-page":"e96421","DOI":"10.1371\/journal.pone.0096421","article-title":"Basal gene expression by lung CD4+ T cells in chronic obstructive pulmonary disease identifies independent molecular correlates of airflow obstruction and emphysema extent","volume":"9","author":"Freeman","year":"2014","journal-title":"PLoS One"},{"key":"R17-20250603","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1177\/0022034511421200","article-title":"Cigarette smoking and inflammation: cellular and molecular mechanisms","volume":"91","author":"Lee","year":"2012","journal-title":"J Dent Res"},{"key":"R18-20250603","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0140-6736(11)60988-4","article-title":"New insights into the immunology of chronic obstructive pulmonary disease","volume":"378","author":"Brusselle","year":"2011","journal-title":"Lancet"},{"key":"R19-20250603","doi-asserted-by":"crossref","first-page":"413735","DOI":"10.1155\/2013\/413735","article-title":"Inflammation and immune response in COPD: where do we stand?","volume":"2013","author":"Rovina","year":"2013","journal-title":"Mediators Inflamm"},{"key":"R20-20250603","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fimmu.2011.00010","article-title":"The role of TLR2 and bacterial lipoprotein in enhancing airway inflammation and immunity","volume":"2","author":"Lugade","year":"2011","journal-title":"Front Immunol"},{"key":"R21-20250603","doi-asserted-by":"crossref","first-page":"693023","DOI":"10.1155\/2013\/693023","article-title":"The immune interplay between the host and the pathogen in Aspergillus fumigatus lung infection","volume":"2013","author":"Sales-Campos","year":"2013","journal-title":"Biomed Res Int"},{"key":"R22-20250603","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1378\/chest.09-3058","article-title":"Expression of the T helper 17-associated cytokines IL-17A and IL-17F in asthma and COPD","volume":"138","author":"Doe","year":"2010","journal-title":"Chest"},{"key":"R23-20250603","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.4049\/jimmunol.1701417","article-title":"Secondhand Smoke Induces Inflammation and Impairs Immunity to Respiratory Infections","volume":"200","author":"Bhat","year":"2018","journal-title":"J Immunol"},{"key":"R24-20250603","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.4049\/jimmunol.1302584","article-title":"Cigarette smoke exposure exacerbates lung inflammation and compromises immunity to bacterial infection","volume":"192","author":"Lugade","year":"2014","journal-title":"J Immunol"},{"key":"R25-20250603","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nature14468","article-title":"T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection","volume":"523","author":"McKinney","year":"2015","journal-title":"Nature"},{"key":"R26-20250603","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev-med-012017-043208","article-title":"CD8 T cell exhaustion in chronic infection and cancer: opportunities for interventions","volume":"69","author":"Hashimoto","year":"2018","journal-title":"Annu Rev Med"},{"key":"R27-20250603","doi-asserted-by":"crossref","first-page":"e71629","DOI":"10.1371\/journal.pone.0071629","article-title":"Down regulation of T cell receptor expression in COPD pulmonary CD8 cells","volume":"8","author":"Grundy","year":"2013","journal-title":"PLoS One"},{"key":"R28-20250603","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1183\/09031936.00079611","article-title":"Systemic CD4+ and CD8+ T-cell cytokine profiles correlate with GOLD stage in stable COPD","volume":"40","author":"Paats","year":"2012","journal-title":"Eur Respir J"},{"key":"R29-20250603","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1378\/chest.10-0779","article-title":"Identification of cells expressing IL-17A and IL-17F in the lungs of patients with COPD","volume":"139","author":"Eustace","year":"2011","journal-title":"Chest"},{"key":"R30-20250603","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1365-2249.2009.03965.x","article-title":"T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients","volume":"157","author":"Di Stefano","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"R31-20250603","first-page":"5324","article-title":"Imbalances of Th17 and Treg cells and their respective cytokines in COPD patients by disease stage","volume":"7","author":"Li","year":"2014","journal-title":"Int J Clin Exp Med"},{"key":"R32-20250603","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1080\/08923973.2016.1188402","article-title":"Th17\/Treg-related cytokine imbalance in sulfur mustard exposed and stable chronic obstructive pulmonary (COPD) patients: correlation with disease activity","volume":"38","author":"Imani","year":"2016","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"R33-20250603","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.4049\/jimmunol.0903162","article-title":"IL-17 promotes p38 MAPK-dependent endothelial activation enhancing neutrophil recruitment to sites of inflammation","volume":"184","author":"Roussel","year":"2010","journal-title":"J Immunol"},{"key":"R34-20250603","doi-asserted-by":"crossref","first-page":"1602434","DOI":"10.1183\/13993003.02434-2016","article-title":"Th17 cytokines: novel potential therapeutic targets for COPD pathogenesis and exacerbations","volume":"50","author":"Le Rouzic","year":"2017","journal-title":"Eur Respir J"},{"key":"R35-20250603","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1084\/jem.20081463","article-title":"Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis","volume":"206","author":"Conti","year":"2009","journal-title":"J Exp Med"},{"key":"R36-20250603","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1086\/422329","article-title":"Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice","volume":"190","author":"Huang","year":"2004","journal-title":"J Infect Dis"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000001183","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T20:31:35Z","timestamp":1748982695000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000001183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,14]]},"references-count":36,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000001183","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,14]]}}}